0001209191-24-002119.txt : 20240123
0001209191-24-002119.hdr.sgml : 20240123
20240123191723
ACCESSION NUMBER: 0001209191-24-002119
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240120
FILED AS OF DATE: 20240123
DATE AS OF CHANGE: 20240123
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Amoroso Michael
CENTRAL INDEX KEY: 0001830874
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38841
FILM NUMBER: 24553908
MAIL ADDRESS:
STREET 1: 1330 AVENUE OF THE AMERICAS
STREET 2: 33RD FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10019
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PRECISION BIOSCIENCES INC
CENTRAL INDEX KEY: 0001357874
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 302 EAST PETTIGREW STREET
STREET 2: SUITE A-100
CITY: DURHAM
STATE: NC
ZIP: 27701
BUSINESS PHONE: 919-314-5512
MAIL ADDRESS:
STREET 1: 302 EAST PETTIGREW STREET
STREET 2: SUITE A-100
CITY: DURHAM
STATE: NC
ZIP: 27701
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2024-01-20
0
0001357874
PRECISION BIOSCIENCES INC
DTIL
0001830874
Amoroso Michael
C/O PRECISION BIOSCIENCES, INC.
302 E. PETTIGREW STREET, SUITE A-100
DURHAM
NC
27701
1
1
0
0
President and CEO
1
Common Stock
2024-01-20
4
M
0
266720
A
493823
D
Common Stock
2024-01-22
4
S
0
137390
0.36
D
356433
D
Restricted Stock Units
2024-01-20
4
M
0
266720
0.00
D
Common Stock
266720
533280
D
Represents the partial vesting and settlement of Restricted Stock Units ("RSUs") on January 20, 2024.
Each RSU represents a contingent right to receive one share of the Issuer's Common Stock or, at the Issuer's option, an amount of cash equal to the fair market value of such share.
The sales were effected pursuant to a Rule 10b5-1 plan adopted on March 24, 2022. The transaction was a sell-to-cover, with shares only sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The Reporting Person did not sell or otherwise dispose of shares reported on this Form 4 for any reason other than to cover required taxes and fees.
On January 20, 2023 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on January 20, 2024, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.
/s/ Dario Scimeca, Attorney-in-Fact for Michael Amoroso
2024-01-23